Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 2012 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 2678 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 2963 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 3962 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 4065 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 4451 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 4968 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 5107 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 5217 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 5223 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 5934 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 6911 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 9023 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (M-H)- | 9515 | Peak area normalized | female | diabetic | Neuropathy |